banner image

Products & Spin Out

Driving improvements in the quality and value of patient care

Aurum Biosciences

Aurum Biosciences Ltd is a 2015 spin-out company of SHIL, NHS Greater Glasgow and Clyde and the University of Glasgow.

A clinical-stage biopharmaceutical company, Aurum is developing novel oxygen carriers and proprietary software for use with MRI, initially for Acute Ischaemic Stroke (AIS), as well as a pipeline of other products.

Headed by a team of experts in the field and working closely with NHS Greater Glasgow and Clyde and the University of Glasgow, Aurum is developing all of its products to address areas of high unmet medical need.

Find out more about Aurum Biosciences.